126 related articles for article (PubMed ID: 25907643)
1. Cause-specific or relative survival setting to estimate population-based net survival from cancer? An empirical evaluation using women diagnosed with breast cancer in Geneva between 1981 and 1991 and followed for 20 years after diagnosis.
Schaffar R; Rachet B; Belot A; Woods L
Cancer Epidemiol; 2015 Jun; 39(3):465-72. PubMed ID: 25907643
[TBL] [Abstract][Full Text] [Related]
2. Estimation of net survival for cancer patients: Relative survival setting more robust to some assumption violations than cause-specific setting, a sensitivity analysis on empirical data.
Schaffar R; Rachet B; Belot A; Woods LM
Eur J Cancer; 2017 Feb; 72():78-83. PubMed ID: 28027519
[TBL] [Abstract][Full Text] [Related]
3. Fair comparisons of cause-specific and relative survival by accounting for the systematic removal of patients from risk-sets.
Wells M; Rutherford MJ; Lambert PC
Cancer Epidemiol; 2023 Oct; 86():102408. PubMed ID: 37591148
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of cause of death data routinely recorded in a population-based cancer registry: impact on cause-specific survival and validation using the Geneva Cancer Registry.
Schaffar R; Rapiti E; Rachet B; Woods L
BMC Cancer; 2013 Dec; 13():609. PubMed ID: 24373194
[TBL] [Abstract][Full Text] [Related]
6. Net survival of women diagnosed with breast tumours: a population-based study in Switzerland.
Karavasiloglou N; Michalopoulou E; Limam M; Korol D; Wanner M; Rohrmann S
Swiss Med Wkly; 2023 Aug; 153():40087. PubMed ID: 37769336
[TBL] [Abstract][Full Text] [Related]
7. Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts.
Dignam JJ; Huang L; Ries L; Reichman M; Mariotto A; Feuer E
Cancer; 2009 Nov; 115(22):5272-83. PubMed ID: 19670456
[TBL] [Abstract][Full Text] [Related]
8. Estimating net survival: the importance of allowing for informative censoring.
Danieli C; Remontet L; Bossard N; Roche L; Belot A
Stat Med; 2012 Apr; 31(8):775-86. PubMed ID: 22281942
[TBL] [Abstract][Full Text] [Related]
9. Improved estimates of cancer-specific survival rates from population-based data.
Howlader N; Ries LA; Mariotto AB; Reichman ME; Ruhl J; Cronin KA
J Natl Cancer Inst; 2010 Oct; 102(20):1584-98. PubMed ID: 20937991
[TBL] [Abstract][Full Text] [Related]
10. Adjusting relative survival estimates for cancer mortality in the general population.
Ellison LF
Health Rep; 2014 Nov; 25(11):3-9. PubMed ID: 25408490
[TBL] [Abstract][Full Text] [Related]
11. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
[TBL] [Abstract][Full Text] [Related]
12. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
14. Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival.
Cronin KA; Feuer EJ
Stat Med; 2000 Jul; 19(13):1729-40. PubMed ID: 10861774
[TBL] [Abstract][Full Text] [Related]
15. Correcting for misclassification and selection effects in estimating net survival in clinical trials.
Goungounga JA; Touraine C; Grafféo N; Giorgi R;
BMC Med Res Methodol; 2019 May; 19(1):104. PubMed ID: 31096911
[TBL] [Abstract][Full Text] [Related]
16. Direct modelling of age standardized marginal relative survival through incorporation of time-dependent weights.
Lambert PC; Syriopoulou E; Rutherford MR
BMC Med Res Methodol; 2021 Apr; 21(1):84. PubMed ID: 33894741
[TBL] [Abstract][Full Text] [Related]
17. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
18. Choice of relative or cause-specific approach to cancer survival analysis impacts estimates differentially by cancer type, population, and application: evidence from a Canadian population-based cohort study.
Withrow DR; Pole JD; Nishri ED; Tjepkema M; Marrett LD
Popul Health Metr; 2017 Jul; 15(1):24. PubMed ID: 28673318
[TBL] [Abstract][Full Text] [Related]
19. Errors in determination of net survival: cause-specific and relative survival settings.
Bright CJ; Brentnall AR; Wooldrage K; Myles J; Sasieni P; Duffy SW
Br J Cancer; 2020 Mar; 122(7):1094-1101. PubMed ID: 32037401
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
